Effect of additive calcium administration on FGF23 levels in patients with mild chronic kidney disease treated with calcitriol: a randomized, open-labeled clinical trial

BACKGROUND: The purpose of the present study was to determine the effect of additional calcium carbonate treatment on fibroblast growth factor 23 (FGF23) levels in patients treated with calcitriol. METHODS: In this randomized, open-labeled, and parallel-group study, a total of 30 patients with early...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Nayoung, Hong, Su Hyun, Kim, Yon Su, Kim, Dong Ki, Kim, In-Wha, Ji, Eunhee, Oh, Jung Mi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565373/
https://www.ncbi.nlm.nih.gov/pubmed/28860784
http://dx.doi.org/10.2147/TCRM.S142564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565373/
https://www.ncbi.nlm.nih.gov/pubmed/28860784
http://dx.doi.org/10.2147/TCRM.S142564

Ejemplares similares